Collaboration - October 10, 2022
Capitainer to collaborate with the University of Florida
The company has entered a collaboration agreement with Timothy J. Garrett Laboratory, College of Medicine, University of Florida. Dr. Tim Garrett is one of the leading experts and an authority in the US when it comes to applying mass spectrometry within the area of metabolomics and its clinical applications. He has a huge network of […]
Collaboration - October 5, 2022
NLSDays 2022: Back in-person and more vibrant than ever
The 9th edition of Nordic Life Science Days offered many discussions, interesting topics, enthusiastic exhibitors, and not least, a pulsating life science atmosphere. Attending NLSDays really made you realize the need for face-to-face meetings and interactions, and despite the ongoing financial and political turbulence in our world, Malmömässan’s visitors brought a feeling of hope and […]
Collaboration - September 27, 2022
Meet us at NLSDays in Booth 35!
NLSDays 2022, taking place at Malmömässan on September 28-29, will offer hot topics, inspiring discussions, and not least, opportunities for the life science community to meet, mingle and create business synergies. Meet Nordic Life Science at NLSDays We will participate in and cover the NLSDays-event directly from Malmömässan. Come by and chat with us in […]
Collaboration - September 27, 2022
Our Nordic Life Science Stars 2022!
These five Nordic life science companies are at different stages of development, with different focus areas, from different Nordic countries, and they represent the different strongholds that the region possesses. Sweden – Abera Bioscience Abera Bioscience has found the right recipe for giving its versatile vaccine platform the best possible conditions to succeed. “Our […]
Agreement - September 26, 2022
TILT Biotherapeutics signs new agreement with MSD
The Finnish company has signed a second clinical trial collaboration and supply agreement with MSD for a new clinical trial evaluating TILT-123, its oncolytic adenovirus armed with two human cytokines, in combination with Keytruda, MSD’s anti-PD-1 therapy. This Phase I, open label, dose escalation trial will include 12 to 24 patients with immune checkpoint inhibitor […]
Collaboration - September 21, 2022
RWE on the agenda at US-Swedish event
During a meeting at the US ambassador’s residence in Sweden on September 20th, collaboration on data driven life sciences and Real World Evidence’s (RWE’s) impact on Swedish life sciences was discussed. The meeting was arranged by MSD, SwedenBIO, Karolinska Institutet and the American Chamber of Commerce. “The event was important in order to showcase concrete […]
